Background: Alternative splicing of the transcripts of the human glucocorticoid receptor gene results in two mutually exclusive products, the dassic, ligand-binding
INTRODUCTION
The existence of two human glucocorticoid receptor (hGR) isoforms, the classic ligand-binding receptor hGRa, and a slightly smaller protein termed hGRf3, was predicted as early as 1985, based on the cDNA cloning experiments by Hollenberg et al. (1) (3) (4) (5) (6) .
As early as 1995, we demonstrated that hGR, expressed from a cDNA clone bound specifically to glucocorticoid-responsive elements (GREs) and acted as a dominant negative inhibitor of hGRa activity in a heterologous COS-7 cell co-transfection system (7) . Indeed, hGRf3 inhibited approximately 50% of the maximum ligand-activated hGRa effect when transfected in 5-fold excess concentrations. These findings were recently replicated in COS-1, CV-1, and HeLa S3 cells, in the last case showing inhibition of endogenous hGRa action by hGR,B as well (8) .
In our earlier study, we also demonstrated that the hGR,B mRNA was expressed in virtually all human tissues examined, suggesting that this isoform might play an important role in defining tissue sensitivity to glucocorticoids (7) . This was recently confirmed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, which allowed computation of a hGR,3-to-hGRa mRNA ratio ranging between 0.21 and 0.34 in human tissues (8) . Two HeLa cells were treated with 10-7 M dexamethasone (dex) or placebo for 30 min, as soon as they reached confluence. At the end of the incubation, they were harvested by trypsinization, centrifuged at 300 x g for 5 min, resuspended, and washed three times with phosphate-buffered saline (PBS). After a fourth 300 x g centrifugation, the cell pellets were frozen on dry ice for 30 min. They were then homogenized in 1 ml Taps buffer (25 mM Taps, 1 mM EDTA, 10% glycerol, pH 8.8, kept at 4°C) containing protease inhibitors (2 g/ml aprotinin, 2 mM phenylmethylsulfonyl fluoride, and 50 jig/ml leupeptin).
The tissue or HeLa cell homogenates were subsequently centrifuged at 300 X g for 10 min, and the pellets were discarded. The new supernatants were recentrifuged at 1000 X g for 10 min to obtain the nuclear fraction in the pellet, which was then dispersed in 0.3 ml of the same buffer and kept frozen at -700C. The supernatants were ultracentrifuged at 105,000 x g for 1 hr, to obtain the cytosolic fraction, which was also kept frozen at -700C, until assay. Protein determination was performed using BCA Protein Assay Reagent (Pierce, Rockford, IL, U.S.A.) and bovine serum albumin (BSA) as a standard.
Antisera Generation and Characterization
Anti-hGRa and -hGRI3 polyclonal antisera were raised in female New Zealand white rabbits immunized with an 18-mer synthetic peptide (QIPKYSNGNIKKLLFHQK) or a 1 5-mer synthetic peptide (NVMWLKPESTSHTLI), derived from the amino acid sequences of the corresponding residues 760-777 or 728-742 of the hGRa and hGR,B proteins, respectively (Fig. 1) . Since short peptides are unlikely to assume the native conformation in solution, we synthesized each oligopeptide in tandem with a "helper" 22-mer sequence (GPSLKLLSLIKGVIVHRLEGVE), which stabilized its conformation, as previously described (14) . The resultant 40 amino acid-long peptides were given to rabbits intradermally at four to five sites in the dorsal flank, with 100 ,ug of peptide per site emulsified in complete Freund's adjuvant. Booster immunizations were performed every 4-5 weeks. Antibody titers were monitored by enzyme-linked immunosorbent assay (ELISA). We selected antisera with titers greater than 1:10,000. The antibodies were affinity-purified on a column prepared by coupling each of the synthetic hGRa-and hGRPspecific oligopeptides to UltraLink (Pierce), as specified by the manufacturer.
The antisera dilutions were selected to provide specific binding with the least amount of nonspecific background. The specificity of the immunoreaction was controlled by substituting the primary antiserum with nonimmunized rabbit serum or by adding no primary antiserum. No immunopositivity was observed in these experiments. Nonspecific protein binding to the nitrocellulose paper was reduced by preincubation of the membranes in 5% milk block for 30 min. Immunoblotting was subsequently performed at 4°C, using our purified antibodies against the hGRaand hGR,B-specific sequences at 5 and 4 ,tg/ml, respectively, and the previously characterized commercially available antibody at 1.75 ,ug/ml, all after an overnight incubation. The following morning, the blots were washed in wash buffer (50 mM sodium phosphate, 150 mM NaCl, and 0.05% Tween 20) for 60 min. The blots were then incubated at room temperature for 1 hr, with peroxidase-conjugated anti-rabbit immunoglobulin antibody (Dako, Carpinteria, CA, U.S.A.) employed at 1:3500, 1:4000, and 1:2500 dilution for our specific anti-hGRa and -hGR,B antibodies and the commercially available antibody, respectively. Washing was then done as described above. To detect immunoreactive bands, blots were exposed to chemiluminescence solution (LumiGlo chemiluminescence substrate; Kirkegard and Perry, Gaithersburg, MD, U.S.A.) for 1 min, followed by exposure to X-OMAT AR Film (Eastman Kodak Co., Rochester, NY, U.S.A.). After film development, the blots were washed with India ink (1 ,ul/ml) for 2 hr, to visualize the protein bands and confirm loading equivalency.
In addition, competition experiments were performed by preincubating the primary antisera overnight with increasing amounts of the corresponding immunogenic peptide. When used in Western analysis, signal intensity of the specific receptor bands diminished as the immunogenic peptide concentration increased, thereby demonstrating the specificity of the primary antisera.
Cross-Immunoadsorptions/Precipitations
Receptors were first immunoadsorbed from HeLa cell extracts containing 100 ,ug of total protein, by incubation with nonimmune rabbit serum, specific polyclonal anti-hGRa or -hGR,3 sera in Taps buffer on ice for 1.5 hr, as described above. The reaction mixture was subsequently incubated with 10% Protein-A Sepharose CL-4B (Pharmacia, Uppsala, Sweden) on ice for 1.5 hr. After a 200 X g centrifugation for 1 min, the pellet was washed three times in dilution buffer (10 mM Tris-HCl, pH 8, 140 mM NaCl, 0.1% Triton X-100, 0. 1% BSA, 0.02 5% sodium azide), followed by a fourth wash with 50 mM Tris-HCl, pH 6.8. The immunoprecipitates were pelleted by a 12,000 X g centrifugation at 4°C for 5 (17) . Peptide standards were prepared by linking the antigenic hGRa or hGR,B immunizing peptides, modified by the addition of an N-terminal cysteine, to maleimide-activated BSA (Imject Activated Immunogen Conjugation Kits, Pierce). The peptide-BSA conjugate was then purified from the free peptide and other reaction impurities by gel filtration chromatography to be used as standards, as described in the manufacturer's instructions and reported previously (17 Fig. 3B . A computer-generated standard curve obtained from densitometry measurements of the peptide-conjugate (y-axis) and the corresponding fmoles of hGR,B peptide-conjugate (x-axis) is presented in Fig. 3C (Fig. 4) . In the absence of dexamethasone, about two-thirds of hGRa immunoreactivity was found in the cytoplasm, and the remaining one-third in the nucleus (Fig. 4, top) . Under the same conditions, about two-thirds of the hGRf3 immunoreactivity was in the cytoplasm, with the remaining immunofluorescence in the nucleus (Fig. 4, bottom) . Translocation of both hGRa and hGRj3 immunoreactivity into the nucleus took place after incubation with dexamethasone, which was virtually maximal for both isoforms by 30 min. Our positive controls, using the commercial anti-N-terminal antibody also detected immunoreactivity in both the cytoplasm and nucleus of HeLa cells, with increasing nuclear content after incubation of the cells with dexamethasone (data not shown). Our negative controls, using preimmune sera or buffer devoid of primary antibody, demonstrated no specific immunofluorescence. Table 1 shows the amount of immunoreactive hGRa and hGR/3 in Western blots from extracts of whole HeLa cells and in the cytosolic and nuclear fractions of these cells before and after 60 min of incubation with 10-7 M of dexamethasone. Although a shift of both hGRa and hGR,B took place from the cytosol to the nucleus after addition of the hormonal ligand, the hGRato-hGRf3 ratio in HeLa cells remained -0.2, independently of the fraction or treatment. This (19) and the naturally occurring thyroid hormone receptor a2 and progesterone receptor A (20) (21) (22) (23) (24) (25) (31, 32) . The former may present with psychiatric, endocrine, or autoimmune manifestations, the latter with metabolic and/or cardiovascular manifestations (33) . We have obtained strong preliminary evidence that the hGRa-tohGR,B ratio is markedly decreased (-50-fold) in cultured lymphoblasts from patients with glucocorticoid resistant asthma type II, a severe form of early life asthma, which is very poorly responsive to glucocorticoids (34, 35) , suggesting that hGR,B may indeed be directly involved in human pathophysiology. The molecular defect(s) leading to this change remains to be examined.
